Anti-inflammatory effect of Kaba Sura Kudineer (AYUSH approved COVID-19 drug)-A Siddha poly-herbal formulation against lipopolysaccharide induced inflammatory response in RAW-264.7 macrophages cells. [PDF]
J Ethnopharmacol, 2022 Jose SP +6 more
europepmc +1 more source
Promising traditional Indian medicinal plants for the management of novel Coronavirus disease: A systematic review. [PDF]
Phytother Res, 2021 Singh RS +13 more
europepmc +1 more source
A Systematic Analysis of COVID-19 Clinical Trials Registered in the Clinical Trials Registry of India. [PDF]
CureusDutta S, Singhal S, Shah R.
europepmc +1 more source
Management of COVID - 19 with Siddha and Western Medicine - An Integrative Case Report. [PDF]
J Family Med Prim Care, 2022 Priya BK +3 more
europepmc +1 more source
Status of evidence on efficacy and safety of Indian traditional medicine (Ayush) for COVID-19: a qualitative review and evidence map synthesis. [PDF]
Syst RevAhmad A +15 more
europepmc +1 more source
Significance of AYUSH: India's first line of defence against COVID-19. [PDF]
J Ayurveda Integr Med, 2021 Patwardhan B, Sarwal R.
europepmc +1 more source
Experiences, Challenges, and Lessons Learned During Implementation of a Remote Monitoring Program for Home-Isolated COVID-19 Patients in Chennai, India. [PDF]
Glob Health Sci Pract, 2023 Ganeshkumar P +9 more
europepmc +1 more source
In silico exploration of phytocompounds from AYUSH-64 medicinal plants against SARS CoV-2 RNA-dependent RNA polymerase. [PDF]
J Ayurveda Integr MedCheemanapalli S +3 more
europepmc +1 more source
Strengthening AYUSH Integration with Preventive Medicine. [PDF]
Indian J Community MedSaxena V +5 more
europepmc +1 more source